• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Retrospective examination of the Hungarian breast and cervical cancer screening programmes according to mortality and morbidity data].

作者信息

Sárváry Attila, Bálint Pál Csaba, Gyulai Anikó, Kósa Zsigmond

机构信息

Ápolástudományi Tanszék, Debreceni Egyetem, Egészségügyi Kar Nyíregyháza, Sóstói út 2-4., 4400.

Kardiológiai Osztály és Kardiológiai Rehabilitációs Osztály, Szent Margit Kórház Budapest.

出版信息

Orv Hetil. 2019 Dec;160(49):1948-1956. doi: 10.1556/650.2019.31518.

DOI:10.1556/650.2019.31518
PMID:31786940
Abstract

The organized breast and cervical screening programs were implemented in the framework of public health program in Hungary in order to reduce breast cancer mortality by 30% and cervical cancer mortality by 60% in given age groups within 10 years by 2012. The aim of our study was to conduct a retrospective analysis of mortality and morbidity data and to evaluate the effectiveness of the implemented screening programs. Descriptive statistical analysis was performed by age-standardized mortality and morbidity data between 1980 and 2015 with special regard to the period of 2002-2012. Breast cancer mortality of women aged 45-64 reduced by 28.3%, the incidence reduced by 23.6% and the incidence of carcinoma increased by 242% between 2002 and 2012. Cervical cancer mortality of women aged 25-64 years reduced by 25.5%, the incidence reduced by 21.2%, and the incidence of carcinoma increased by 13.3% during 2002-2012. Although both breast cancer and cervical cancer mortality substantially decreased in Hungary, the decrease in cervical cancer did not reach the target value. Orv Hetil. 2019; 160(49): 1948-1956.

摘要

相似文献

1
[Retrospective examination of the Hungarian breast and cervical cancer screening programmes according to mortality and morbidity data].
Orv Hetil. 2019 Dec;160(49):1948-1956. doi: 10.1556/650.2019.31518.
2
Nationwide screening program for breast and cervical cancers in Hungary: special challenges, outcomes, and the role of the primary care provider.匈牙利全国乳腺癌和宫颈癌筛查项目:特殊挑战、成果及初级保健提供者的作用
Eur J Gynaecol Oncol. 2013;34(5):419-24.
3
[Cervical cancer incidence and mortality rates including the screening program results in the Podkarpackie Region between 1999-2010].[1999年至2010年间波德卡尔帕希地区宫颈癌发病率和死亡率,包括筛查项目结果]
Ginekol Pol. 2013 Nov;84(11):930-7. doi: 10.17772/gp/1662.
4
[Attendance of the fourth (2008-2009) screening round of the Hungarian organized, nationwide breast cancer screening program].[匈牙利组织的全国性乳腺癌筛查项目第四次(2008 - 2009年)筛查轮次的参与情况]
Orv Hetil. 2013 Dec 1;154(50):1975-83. doi: 10.1556/OH.2013.29744.
5
Breast and cervical cancer screening programme implementation in 16 countries.16 个国家的乳腺癌和宫颈癌筛查计划实施情况。
J Med Screen. 2010;17(3):139-46. doi: 10.1258/jms.2010.010033.
6
Social disparities in access to breast and cervical cancer screening by women living in Spain.西班牙女性在获得乳腺癌和宫颈癌筛查方面的社会差异。
Public Health. 2015 Jul;129(7):881-8. doi: 10.1016/j.puhe.2015.02.021. Epub 2015 Mar 25.
7
[Responsible cancer screening].[责任性癌症筛查]
Ned Tijdschr Geneeskd. 2011;155(45):A3934.
8
[Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].[匈牙利乳腺癌筛查项目第三轮(2006 - 2007年)的参与率]
Magy Onkol. 2013 Sep;57(3):140-6. Epub 2013 Aug 9.
9
[Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].[2013年中国35-69岁女性宫颈癌和乳腺癌筛查覆盖率及社会经济因素相关影响研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Feb 10;39(2):208-212. doi: 10.3760/cma.j.issn.0254-6450.2018.02.014.
10
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.北欧国家癌症筛查对截至2017年的死亡、成本和生活质量的影响。
Acta Oncol. 1997;36 Suppl 9:1-60.

引用本文的文献

1
Cancer prevalence and its determinants in Hungary: Analyzing data from the 2009, 2014, and 2019 European Health Interview Surveys.匈牙利的癌症患病率及其决定因素:分析2009年、2014年和2019年欧洲健康访谈调查的数据。
PLoS One. 2025 Feb 13;20(2):e0315689. doi: 10.1371/journal.pone.0315689. eCollection 2025.
2
Challenges and opportunities for improvement in the management and financing system of Health Promotion Offices in Hungary.匈牙利健康促进办公室管理和融资系统的改进挑战和机遇。
Front Public Health. 2023 Oct 27;11:1219186. doi: 10.3389/fpubh.2023.1219186. eCollection 2023.
3
Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020.
匈牙利年轻和老年女性队列中乳腺癌发病率的相反趋势以及新冠疫情的影响:一项2011年至2020年的全国性研究
Front Oncol. 2023 Sep 18;13:1182170. doi: 10.3389/fonc.2023.1182170. eCollection 2023.